Recent developments in the significance and therapeutic relevance of neuroactive steroids - Introduction to the special issue

Pharmacology and Therapeutics

Volumn 116, Issue 1, 2007, Pages 1-6

  Morrow, A Leslie ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Alcoholism; Depressive disorders; Epilepsy; GABAergic neuroactive steroids; Neurodegeneration; Neuroinflammation

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 3ALPHA,21 DIHYDROXY 5ALPHA PREGNAN 20 ONE; 3ALPHA,21 DIHYDROXY 5BETA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID A RECEPTOR; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; ELTANOLONE; HYDROCORTISONE; MYELIN; NEUROSTEROID; PRASTERONE; PROGESTERONE; UNCLASSIFIED DRUG;

ALCOHOLISM; CENTRAL NERVOUS SYSTEM DISEASE; DEGENERATIVE DISEASE; DEPRESSION; DRUG BINDING SITE; DRUG RECEPTOR BINDING; EPILEPSY; GABAERGIC SYSTEM; GABAERGIC TRANSMISSION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFLAMMATION; MULTIPLE SCLEROSIS; NERVE CELL EXCITABILITY; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SCHIZOPHRENIA; SYNAPTIC TRANSMISSION; TRAUMATIC BRAIN INJURY;

BIOSYNTHETIC PATHWAYS; HUMANS; NEURODEGENERATIVE DISEASES; STEROIDS; SYNAPTIC TRANSMISSION; TERMINOLOGY AS TOPIC;

EID: 34548557525     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2007.04.003     Document Type: Review

References (44)

1. Barbaccia M.L., Affricano D., Trabucchi M., Purdy R.H., Colombo G., Agabio R., et al. Ethanol markedly increases "GABAergic" neurosteroids in alcohol-preferring rats. Eur J Pharmacol 384 (1999) R1-R2
2. Biggio G., and Purdy R.H. Neurosteroids and Brain Function (2001), Academic Press, San Diego
3. Callachan H., Cottrell G.A., Hather N.Y., Lambert J.J., Nooney J.M., and Peters J.A. Modulation of the GABAA receptor by progesterone metabolites. Proc R Soc Lond B Biol Sci 231 (1987) 359-369
4. Chandra D., Jia F., Liang J., Peng Z., Suryanarayanan A., Werner D.F., et al. GABAA receptor alpha 4 subunits mediate extrasynaptic inhibition in thalamus and dentate gyrus and the action of gaboxadol. Proc Natl Acad Sci U S A 103 (2006) 15230-15235
5. Farb D.H., and Gibbs T.T. Steroids as modulators of amino acid receptor function. In: Stone T.W. (Ed). CNS Neurotransmitters and Neuromodulators: Neuroactive Steroids (1996), CRC Press, New York 23-36
6. Frye C.A., Van Keuren K.R., and Erskine M.S. Behavioral effects of 3α-androstanediol: 1. Modulation of sexual receptivity and promotion of GABA-stimulated chloride flux. Behav Brain Res 79 (1996) 109-118
7. Gee K.W., Brinton R.E., Chang W.C., and McEwen B.S. Gamma-aminobutyric acid-dependent modulation of the chloride ionophore by steroids in rat brain. Eur J Pharmacol 136 (1987) 419-423
8. Harrison N.L., Majewska M.D., Harrington J.W., and Barker J.L. Structure-activity relationships for steroid interaction with the gamma-aminobutyric acid-A receptor complex. Pharmacol Exp Ther 241 (1987) 346-353
9. Hirani K., Khisti R.T., and Chopde C.T. Behavioral action of ethanol in Porsolt's forced swim test: modulation by 3α-hydroxy-5α-pregnan-20-one. Neuropharmacology 43 (2002) 1339-1350
10. Hirani K., Sharma A.N., Jain N.S., Ugale R.R., and Chopde C.T. Evaluation of GABAergic neuroactive steroid 3alpha-hydroxy-5alpha-pregnane-20-one as a neurobiological substrate for the anti-anxiety effect of ethanol in rats. Psychopharmacology 180 (2005) 267-278
11. Hosie A.M., Wilkins M.E., da Silva H.M., and Smart T.G. Endogenous neurosteroids regulate GABA(A) receptors through two discrete transmembrane sites. Nature 444 (2006) 486-489
12. Kaminski R.M., Marini H., Kim W., and Rogawski M.A. Anticonvulsant activity of androsterone and etiocholanolone. Epilepsia 46 (2005) 819-827
13. Kaminski R.M., Marini H., Ortinski P.I., Vicini S., and Rogawski M.A. The pheromone androstenol (5 alpha-androst-16-en-3 alpha-ol) is a neurosteroid positive modulator of GABAA receptors. J Pharmacol Exp Ther 317 (2006) 694-703
14. Khisti R.T., VanDoren M.J., O'Buckley T.K., and Morrow A.L. Neuroactive steroid 3α-hydroxy-5α-pregnan-20-one modulates ethanol-induced loss of righting reflex in rats. Brain Res 980 (2003) 255-265
15. Khisti R.T., VanDoren M.J., Matthews D.B., and Morrow A.L. Ethanol-induced elevation of 3alpha-hydroxy-5alpha-pregnan-20-one does not modulate motor incoordination in rats. Alcohol Clin Exp Res 28 (2004) 1249-1256
16. Majewska M.D., Harrison N.L., Schwartz R.D., Barker J.L., and Paul S.M. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 232 (1986) 1004-1007
17. Marx C.E., Stevens R.D., Shampine L.J., Uzunova V., Trost W.T., Butterfield M.I., et al. Neuroactive steroids are altered in schizophrenia and bipolar disorder: relevance to pathophysiology and therapeutics. Neuropsychopharmacology 31 (2006) 1249-1263
18. Matthews D.B., Morrow A.L., Tokunaga S., and McDaniel J.R. Acute ethanol administration and acute allopregnanolone administration impair spatial memory in the Morris water task. Alcohol Clin Exp Res 26 (2002) 1747-1751
19. Mihalek R.M., Banerjee P.K., Korpi E.R., Quinlan J.J., Firestone L.L., Mi Z.P., et al. Attenuated sensitivity to neuroactive steroids in gamma-aminobutyrate type A receptor delta subunit knockout mice. Pro Natl Acad Sci U S A 96 (1999) 12905-12910
20. Morrow A.L., Suzdak P.D., and Paul S.M. Steroid hormone metabolites potentiate GABA receptor-mediated chloride ion flux with nanomolar potency. Eur J Pharmacol 142 (1987) 483-485
21. Morrow A.L., Pace J.R., Purdy R.H., and Paul S.M. Characterization of steroid interactions with g-aminobutyric acid receptor-gated chloride ion channels: evidence for multiple steroid recognition sites. Mol Pharmacol 37 (1990) 263-270
22. Morrow A.L., VanDoren M.J., and Devaud L.L. Effects of progesterone or neuroactive steroid?. Nature 395 (1998) 652-653
23. Morrow A.L., Janis G.C., VanDoren M.J., Matthews D.B., Samson H.H., Janak P.H., et al. Neurosteroids mediate pharmacological effects of ethanol: a new mechanism of ethanol action?. Alcohol Clin Exp Res 23 (1999) 1933-1940
24. Morrow A.L., VanDoren M.J., Penland S.N., and Matthews D.B. The role of GABAergic neuroactive steroids in ethanol action, tolerance and dependence. Brain Res Brain Res Rev 37 (2001) 98-109
25. Morrow A.L., Porcu P., Boyd K.N., and Grant K.A. Hypothalamic-pituitary-adrenal axis modulation of GABAergic neuroactive steroids influences ethanol sensitivity and drinking behavior. Dialogues Clin Neurosci 8 (2006) 463-477
26. O'Dell L.E., Alomary A.A., Vallee M., Koob G.F., Fitzgerald R.L., and Purdy R.H. Ethanol-induced increases in neuroactive steroids in the rat brain and plasma are absent in adrenalectomized and gonadectomized rats. Eur J Pharmacol 484 (2004) 241-247
27. Owens M.J., Ritchie J.C., and Nemeroff C.B. 5α-Pregnane-3α,21-diol-20-one (THDOC) attenuates mild stress-induced increases in plasma corticosterone via a non-glucocorticoid mechanism: comparison with alprazolam. Brain Res 573 (1992) 353-355
28. Park-Chung M., Malayev A., Purdy R.H., Gibbs T.T., and Farb D.H. Sulfated and unsulfated steroids modulate gamma-aminobutyric acid A receptor function through distinct sites. Brain Res 830 (1999) 72-87
29. Patchev V.K., Shoaib M., Holsboer F., and Almeida O.F.X. The neurosteroid tetrahydroprogesterone counteracts corticotropin-releasing hormone-induced anxiety and alters the release and gene expression of corticotropin-releasing hormone in the rat hypothalamus. Neuroscience 62 (1994) 265-271
30. Patchev V.K., Hassan A.H.S., Holsboer F., and Almeida O.F.X. The neurosteroid tetrahydroprogesterone attenuates the endocrine response to stress and exerts glucocorticoid-like effects on vasopressin gene transcription in the rat hypothalamus. Neuropsychopharmacology 15 (1996) 533-540
31. Paul S.M., and Purdy R.H. Neuroactive steroids. FASEB J 6 (1992) 2311-2322
32. Penland S., and Morrow A.L. 3α,5β-Reduced cortisol exhibits antagonist properties on cerebral cortical GABAA receptors. Eur J Pharmacol 506 (2004) 129-132
33. Pierucci-Lagha A., Covault J., Feinn R., Nellissery M., Hernandez-Avila C., Oncken C., et al. GABRA2 alleles moderate the subjective effects of alcohol, which are attenuated by finasteride. Neuropsychopharmacology 30 (2005) 1193-1203
34. Porcu P., Grant K.A., Green H.L., Rogers L.S., and Morrow A.L. Hypothalamic-pituitary-adrenal axis and ethanol modulation of deoxycorticosterone levels in cynomolgus monkeys. Psychopharmacology 186 (2006) 293-301
35. A receptors. Neuron 4 (1990) 759-765
36. - currents. Mol Pharmacol 39 (1991) 691-696
37. Purdy R.H., Fitzgerald R.L., Everhart E.T., Mellon S.H., Alomary A.A., and Parsons L.H. The analysis of neuroactive steroids by mass spectrometry. In: Baker G., et al. (Ed). Handbook of neurochemistry and molecular neurobiology: Practical neurochemistry methods (2006), Springer, New York 1-18
38. Romeo E., Ströhle A., Spalletta G., di Michele F., Hermann B., Holsboer F., et al. Effects of antidepressant treatment on neuroactive steroids in major depression. Am J Psychiatry 155 (1998) 910-913
39. Schuckit M.A. Low level of response to alcohol as a predictor of future alcoholism. Am J Psychiatry 151 (1994) 184-189
40. Schuckit M.A., and Smith T.L. An 8-year follow-up of 450 sons of alcoholic and control subjects. Arch Gen Psychiatry 53 (1996) 202-210
41. Schule C., Romeo E., Uzunov D.P., Eser D., Di Michele F., Baghai T.C., et al. Influence of mirtazapine on plasma concentrations of neuroactive steroids in major depression and on 3alpha-hydroxysteroid dehydrogenase activity. Mol Psychiatry 11 (2006) 261-272
42. Uzunova V., Sheline Y., Davis J.M., Rasmusson A., Uzunov D.P., Costa E., et al. Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc Natl Acad Sci U S A 95 (1998) 3239-3244
43. VanDoren M.J., Matthews D.B., Janis G.C., Grobin A.C., Devaud L.L., and Morrow A.L. Neuroactive steroid 3α-hydroxy-5α-pregnan-20-one modulates electrophysiological and behavioral actions of ethanol. J Neurosci 20 (2000) 1982-1989
44. Xue B.G., Whittemore E.R., Park C.H., Woodward R.M., Lan N.C., and Gee K.W. Partial agonism by 3α,21-dihydroxy-5β-pregnan-20-one at the gamma-aminobutyric acid, receptor neurosteroid site. J Pharmacol Exp Ther 281 (1997) 1095-1101